2-(2-BROMO-5,6-DICHLOROBENZIMIDAZOL-1-YL)-5-(HYDROXYMETHYL)OXOLANE-3,4-DIOL, (2R,3S,4R,5S)-
UNII 8V2YY27QKK

Substance Identification & Data

This profile provides standardized clinical and technical data for 2-(2-bromo-5,6-dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol, (2r,3s,4r,5s)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 8V2YY27QKK.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
8V2YY27QKK
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
2-(2-BROMO-5,6-DICHLOROBENZIMIDAZOL-1-YL)-5-(HYDROXYMETHYL)OXOLANE-3,4-DIOL, (2R,3S,4R,5S)-
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C12H11BrCl2N2O4
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
NMAMPJIAXSGTLN-XWLWVQCSSA-N
Line notation for describing the chemical structure and connectivity of atoms.
PubChem CID
141940954
Unique identification number in the NCBI database of chemical substances.
Substance Type
2-(2-Bromo-5,6-dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol, (2R,3S,4R,5S)-
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
c1c(c(cc2c1nc(Br)n2[C@H]3[C@H]([C@H]([C@H](CO)O3)O)O)Cl)Cl

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for 2-(2-bromo-5,6-dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol, (2r,3s,4r,5s)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Systematic Nomenclature

(2R,3S,4R,5S)-2-(2-Bromo-5,6-dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol
2-(2-Bromo-5,6-dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol, (2R,3S,4R,5S)-

External Clinical & Regulatory Resources

NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NLM
PubChem Compound